(Q53060881)
Statements
Cost-utility analysis of the GC versus MVAC regimens for the treatment of locally advanced or metastatic bladder cancer. (English)
Paul Robinson
Hans von der Maase
Shkun Bhalla
Adrian Kielhorn
Michael Aristides
Alissa Brown
Dominic Tilden
1 February 2004
4
1
27-38